We created this video for the University of Chicago Medicine Comprehensive Cancer Center to help them raise awareness in order to achieve breakthroughs in the fight against this debilitating disease. ----------- What is the future of cancer care? Well, it's no longer determined solely by the location of the tumor -- the old "one size fits all" approach. No, the future of cancer care lays in personalized medicine -- tailoring treatment based on the unique environmental, social and biological factors -- including genetics -- of each cancer. The future of cancer is NOW at the University of Chicago Medicine Comprehensive Cancer Center! Recognized as 1 of only 41 leading National Cancer Institute-designated centers, we have been at the forefront of cancer care and discovery since the 1970's. That's when the brilliant, tireless and internationally-known Dr. Janet D. Rowley discovered a vital breakthrough in understanding the relationship between cancer and genetics -- a game changer that led to finding key genetic mutations in every type of cancer. And Dr.
It's all about you, helping you understand and helping you heal.
If you've been told you need surgery, the physicians at the University of Chicago Medical Center can help. Our teams of expert surgeons have access to the latest research and most advanced technology. From complex brain or open-heart operations to simple outpatient procedures, our surgeons offer the latest advances in care for adults and children.
Cancer researchers at the University of Chicago and five other leading institutions will share equally in a $540 million gift from Ludwig Cancer Research, on behalf of its founder Daniel K. Ludwig. Ludwig Cancer Research is an international community of researchers dedicated to pursuing life-changing discoveries to alter the course of cancer. Find out more at: http://www.uchospitals.edu/news/2014/20140106-ludwig.html
Janet Rowley, MD, sparked a revolution in cancer genetics and continues to shape the field of personalized medicine today. Rowley and her fellow University of Chicago colleagues, Michelle LeBeau, PhD, director, University of Chicago Comprehensive Cancer Center; Vinay Kumar, MBBS, MD, chair, Department of Pathology; and Richard Schilsky, MD, chief, Section of Hematology/Oncology; talk about this groundbreaking research and current advances in targeted therapy for cancer care.
Pediatric oncologist and brain tumor expert Charles M. Rubin, MD, describes the diagnosis, treatment and recovery for pediatric brain tumors. Rubin and his colleagues at Comer Children's Hospital at the University of Chicago have many years of experience treating children with benign and malignant brain tumors. These experts are involved in important research to understand the biology of pediatric brain tumors with the goal of developing new treatments.
If a child has cancer, what is the risk for cancer in other children and family members? Kenan Onel, MD, PhD, talks about how the Familial Cancer Clinic at Comer Children's Hospital helps families assess the risk for hereditary cancer syndromes. If family members have an increased risk of cancer, clinic experts develop individualized action plans to reduce cancer risk.